Cargando…
S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study
BACKGROUND: Electroconvulsive therapy (ECT) is one of the most effective treatment options for refractory depressed patients. To date, there are only a few predictors of response. AIM: The aim was to identify predictive biomarkers of remission to ECT on a molecular level. METHODS: 11 patients suffer...
Autores principales: | Maier, Hannah, Helm, Saskia, Toto, Sermin, Moschny, Nicole, Sperling, Wolfgang, Hillemacher, Thomas, Kahl, Kai G., Jakubovski, Ewgeni, Bleich, Stefan, Frieling, Helge, Neyazi, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818900/ https://www.ncbi.nlm.nih.gov/pubmed/29545905 http://dx.doi.org/10.1155/2018/2358451 |
Ejemplares similares
-
Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients
por: Maier, Hannah Benedictine, et al.
Publicado: (2022) -
Epinephrine levels decrease in responders after electroconvulsive therapy
por: Pollak, Christoph, et al.
Publicado: (2021) -
DNA Methylation of
POMC
and
NR3C1-1F
and Its
Implication in Major Depressive Disorder and Electroconvulsive
Therapy
por: Maier, Hannah B., et al.
Publicado: (2023) -
DNA Methylation of the t-PA Gene Differs Between Various Immune Cell Subtypes Isolated From Depressed Patients Receiving Electroconvulsive Therapy
por: Moschny, Nicole, et al.
Publicado: (2020) -
Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy
por: Moschny, Nicole, et al.
Publicado: (2020)